tilorone has been researched along with Bacillus anthracis Infection in 1 studies
Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.
Excerpt | Relevance | Reference |
---|---|---|
"To date, anthrax is treatable if antibiotics are administered promptly and continued for 60 days." | 2.53 | Alternative pre-approved and novel therapies for the treatment of anthrax. ( Head, BM; Meyers, AF; Rubinstein, E, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Head, BM | 1 |
Rubinstein, E | 1 |
Meyers, AF | 1 |
1 review available for tilorone and Bacillus anthracis Infection
Article | Year |
---|---|
Alternative pre-approved and novel therapies for the treatment of anthrax.
Topics: Alpha-Globulins; Anthrax; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibodies, Monoclonal | 2016 |